PALISADE BIO, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.49 USD | -3.28% |
|
-21.62% | -25.07% |
| May. 10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
| May. 07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 8.460 | 14.40 | 11.33 |
| Spread/Res. | -21.62% | -53.95% | -41.47% |
| Spread/Supp. | +9.97% | +62.92% | +60.95% |
| Support | 6.030 | 4.070 | 4.120 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- SNCA Stock
- Charts Palisade Bio, Inc.